Endometriosis prophylaxis and treatment with the newly developed xenogenic immunomodulator RESAN in an animal model

Published:November 12, 2008DOI:



      The objective was to assess the effectiveness of the newly developed immunomodulator RESAN in the prophylaxis and treatment of endometriosis induced in rats.

      Study design

      The study was performed on 58 Wistar rats. Twelve weeks before endometriosis induction, the RESAN vaccine was administered to 24 rats (100 mg i.m. and 100 mg s.c.). Endometriosis induction was performed in 48 rats, which were divided into two groups: group I, the prophylaxis group, consisting of 24 previously vaccinated rats; and group II, the treatment group, comprising the other 24 rats, which had not been vaccinated. The graft (4 mm × 4 mm) of endometrium was attached to the parietal peritoneum. A sham operation was performed in 10 rats (group III). After 3 months, a second laparotomy was performed in all animals, and endometriotic foci were excised when present. RESAN was administered to the group II animals. After an additional 3 months, a third laparotomy was performed in all animals of the three groups.


      Positive, histologically confirmed endometriosis was found in 4.3% of the animals in group I and in 69.6% of group II rats (p < 0.0001). Macroscopic assessment revealed endometriosis in 21.7% and 91.3% of animals in groups I and II, respectively (p < 0.0001). At final laparotomy, 3 months after excision of the previously suspected foci, no signs of endometriosis were found according to both macroscopic assessment and histological examination. During the second laparotomy intraperitoneal adhesions were present in 13.0% of the animals in group I and in 61.0% of those in group II. No adhesions were present in group III. At the final laparotomy, the adhesions were present in only three of the animals in group II (p < 0.0009).


      RESAN seems to be effective in both the prophylaxis and treatment of endometriosis, as well as in the prophylaxis of adhesions. Histological confirmation of endometriosis should be mandatory.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Audebert A.
        • Bäckström T.
        • Barlow D.
        • et al.
        Endometriosis 1991: a discussion document.
        Hum Reprod. 1992; 7: 423-435
        • D’Hooghe T.
        • Xiao L.
        • Hill J.
        Cytokine profiles in autologous peritoneal fluid and peripheral blood of women with deep and superficial endometriosis.
        Arch Gynecol Obstet. 2001; 265: 40-44
        • Redwine D.
        Was Sampson wrong?.
        Fertil Steril. 2002; 78: 686-693
        • Vinatier D.
        • Cosson M.
        • Dufour P.
        Is endometriosis an endometrial disease?.
        Eur J Obstet Gynecol Reprod Biol. 2000; 91: 113-125
        • Mangtani P.
        • Booth M.
        Epidemiology of endometriosis.
        J Epidemiol Community Health. 1993; 47: 84-88
        • Farquhar C.M.
        Extracts from the “clinical evidence” Endometriosis.
        BMJ. 2000; 320: 1449-1452
        • D’Hooghe T.M.
        • Debrock S.
        • Hill J.A.
        • Meuleman C.
        Endometriosis and subfertility: is the relationship resolved?.
        Semin Reprod Med. 2003; 21: 243-254
        • Harris J.E.
        • Ryan L.
        • Hoover H.C.
        • et al.
        Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Study (E5283).
        J Clin Oncol. 2000; 58: 215-218
        • Knutson K.L.
        • Schiffman K.
        • Cheever M.A.
        • Disis M.L.
        Immunization of cancer patients with a HER-2/neu, HLA-A2 peptide, p369-377, results in short-lived peptide-specific immunity.
        Clin Cancer Res. 2002; 8: 1014-1018
        • Itil I.M.
        • Cirpan T.
        • Akercan F.
        • et al.
        Effect of BCG vaccine on peritoneal endometriotic implants in a rat model of endometriosis.
        Aus NZ J Obstet Gynecol. 2006; 46: 38-41
        • Gul A.
        • Yaspar T.
        • Ugras S.
        BCG vaccination to prevent implantation of endometriosis: an experimental study in rats.
        Eur J Obstet Gynecol Reprod Biol. 2001; 98: 209-212
        • Balasch J.
        • Creus M.
        • Fabregas F.
        • et al.
        Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial.
        Hum Reprod. 1997; 12: 2046-2050
      1. Yantchenko VV, Yantchenko AV, Yantchenko LK. Imitators of the tumor antigens. The patent committee RB, appl. N970547; 1997.

        • Florek E.
        • Szymanowski K.
        • Wrzosek J.
        • Piekoszewski W.
        • Biczysko W.
        • Marszałek A.
        The influence of simultaneous whole body exposure to cigarette smoke and low-protein diet feeding on fertility, reproduction and progeny of rats.
        Hum Exp Toxicol. 2002; 21: 615-621
        • Jędrzejczak P.
        • Szymanowski K.
        • Skrzypczak J.
        • Pisarski T.
        [ekspermantalny model endometriozy u szczurów] The experimental model of endometriosis in rats.
        Ginek Pol. 1990; 61: 387-391
        • Szymanowski K.
        • Florek E.
        • Mikołajczyk M.
        • Skrzypczak J.
        Integrin pattern in rats endometrium after endometriosis induction.
        Pol J Gynaecol Invest. 2002; 5: 293-298
        • Szymanowski K.
        • Mikołajczyk M.
        • Rączyńska P.
        • Florek E.
        • Skrzypczak J.
        Integrin pattern in rats endometrium after endometriosis excision.
        Pol J Gynaecol Invest. 2002; 5: 299-302
        • Szymanowski K.
        • Mikołajczyk M.
        • Skrzypczak J.
        Apoptosis expression in rats’ endometrium after surgical induction of endometriosis.
        Ginek Pol. 2003; 74: 262-266
      2. The patent committee of Republic of Belarus, No. 5942; 1997.

        • Dmowski W.P.
        • Braun D.P.
        Immunology of endometriosis.
        Best Pract Res Clin Obstet Gynaecol. 2004; 18: 245-263
        • Szymanowski K.
        Apoptosis pattern in human endometrium in women with pelvic endometriosis.
        Eur J Obstet Gynecol Reprod Biol. 2007; 132: 107-110
        • Hoover Jr., H.C.
        • Brandhorst J.S.
        • Peters L.C.
        • et al.
        Adjuvant active specific immunotherapy for human colorectal cancer: 6, 5-year median follow-up of phase III prospective randomized trial.
        J Clin Oncol. 1993; 11: 390-399
        • Mittelman A.
        • Chen Z.J.
        • Yang H.
        • Wong G.Y.
        • Ferrone S.
        Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.
        Proc Natl Acad Sci USA. 1992; 15: 466-470
        • Schultz N.
        • Oratz R.
        • Chen D.
        • et al.
        Effect of DETOX as an adjuvant for melanoma vaccine.
        Vaccine. 1995; 13: 503-508
        • Helling F.
        • Zhang S.
        • Shang A.
        • et al.
        GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21.
        Cancer Res. 1995; 55: 2783-2788